TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo.
Mueller
L P
LP
Department of Internal Medicine IV, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. lutz.mueller@medizin.uni-halle.de
Luetzkendorf
J
J
Widder
M
M
Nerger
K
K
Caysa
H
H
Mueller
T
T
D000818:Animals; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D019008:Drug Resistance, Neoplasm; D019073:HT29 Cells; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism*; D051379:Mice; D008819:Mice, Nude; D039902:Multipotent Stem Cells / Q000166:cytology / Q000378:metabolism*; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000235:genetics* / Q000378:metabolism; D014161:Transduction, Genetic; D014183:Transplantation, Heterologous
D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand